KALYDECO
Live / Registered — Registered and renewed (as of 14 Oct 2021)
What this means for you
Registered since 22 May 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 May 2032: the §8 & §9 renewal).
Record
- Serial number
- 85155478
- Registration number
- 4147369
- Mark type
- Word mark
- Filed
- 18 Oct 2010
- Published for opposition
- 23 Aug 2011
- Registered
- 22 May 2012
- Current term from
- 22 May 2022
- Next maintenance filing
- §8 & §9 renewal, due by 22 May 2032 (grace period to 22 Nov 2032)
- Attorney of record
- Lisa Tittemore
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 02 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Oct 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Oct 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jun 2021 — TEAS SECTION 8 & 9 RECEIVED
- 22 May 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Dec 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 11 Dec 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Dec 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Nov 2017 — TEAS SECTION 8 & 15 RECEIVED
- 22 May 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED